Immunome

Immunome is a biopharmaceutical company using proprietary human memory B cell platform to develop antibody therapeutics.

pay deal hand over cash licensing transaction money
Biotech

Immunome pays $50M for Ayala's phase 3 desmoid tumor drug

Two months after SpringWorks secured the first FDA approval for desmoid tumors, Immunome has bought a drug it claims could be more effective.
James Waldron Feb 6, 2024 9:50am
christmas stocking holiday tree festive

Christmas deal spree: See what J&J, Roche had in their stockings

Jan 2, 2024 7:35am
parachute chutes and ladders

Google DeepMind vet to join GSK—Chutes & Ladders

Oct 20, 2023 9:30am
parasail Blue Lagoon parachute

Abbvie's president adds COO title—Chutes & Ladders

Jun 30, 2023 9:30am
Pac man eat MA deal buy sell merger

Immunome, Morphimmune reverse merge with Clay Siegall as CEO

Jun 29, 2023 10:50am
An artists rendering of the BQ 11 variant of COVID-19

Immunome decides not to top up its COVID antibody cocktail

Mar 16, 2023 10:05am